Concepedia
Statistics
Publications
7
Citations
178
H-Index
Active since
1997
Affiliations
Inserm(Current)
Hôpital Saint-Antoine
Sorbonne Université
Centre National de la Recherche Scientifique
Marc Hillairet de Boisferon is an author at Inserm specializing in medicine, oncology, and antibody-antigen recognition.
Publications per year
1997–2023
Bivalent Hapten-Bearing Peptides Designed for Iodine-131 Pretargeted Radioimmunotherapy
Emilija Janevik-Ivanovska, Emmanuel Gautherot, Marc Hillairet de Boisferon et al. · Bioconjugate Chemistry · 1997 · 46 citations
Medicine, Biotechnology, Oncology +17
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms
Makoto Asano, Junji Matsui, Murray J. Towle et al. · Anticancer Research · 2018 · 34 citations
Medicine, Oncology, Pharmacology +15
Europium-Labeled Epidermal Growth Factor and Neurotensin: Novel Probes for Receptor-Binding Studies
Ohad Mazor, Marc Hillairet de Boisferon, Alain Lombet et al. · Analytical Biochemistry · 2002 · 28 citations
Life Sciences, Neuroscience, Pharmacology +12
Improved Tumor Selectivity of Radiolabeled Peptides by Receptor and Antigen Dual Targeting in the Neurotensin Receptor Model
Marc Hillairet de Boisferon, Olivier Raguin, Cynthia Thiercelin et al. · Bioconjugate Chemistry · 2002 · 27 citations
Medicine, Oncology, Pharmacology +17
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 7